Indonesia’s Bio Farma on track for COVID-19 vaccine Phase III clinical trial, eyes halal certification
JAKARTA – Indonesia’s state-owned Bio Farma will seek halal certification for a COVID-19 vaccine it is developing with Chinese firm Sinovac Biotech, Honesti Basyir, its CEO told Salaam Gateway.
The CoronaVac is currently in Phase III clinical trials that is expected to be completed within the next six months, according to Honesti. It is currently one of 29 candidate vaccines in clinical evaluation on the WHO’s list.
The biopharmaceutical company will apply for halal certification from Indonesia’s BPJPH when the vaccine is ready to be mass produced.
Continue reading
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Joined by 12,000+ Islamic economy professionals
Create a free account
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
